sales@reportocean.com (Bussiness Sales)
+18882123539 (Us - Toll Free)
+919997112116 (Rest Of World)
Cough Syrup Market by Product Type (Expectorants, Cough Suppressants/Antitussives, and Combination Medications), Age Group (Pediatric and Adult), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2020-2027

Cough Syrup Market by Product Type (Expectorants, Cough Suppressants/Antitussives, and...

Home / Categories / Healthcare
Cough Syrup Market by Product Type (Expectorants, Cough Suppressants/Antitussives, and Combination Medications), Age Group (Pediatric and Adult), and Distribution Channel (Retail Pharmacy, Hospital Pharmacy, and Online Pharmacy): Global Opportunity Analysis and Industry Forecast, 2020-2027
Cough Syrup Market by Product...
Report Code
RO1/113/1760

Publish Date
24/Feb/2021

Pages
240
PRICE
$ 1800/-
This is a single user license, allowing one specific user access to the product. The product is a PDF.
$ 2350/-
This is a 1-5 user license, allowing up to five users have access to the product. The product is a PDF.
$ 2850/-
This is an enterprise license, allowing all employees within your organization access to the product. The product is a PDF..
CHAPTER 1:INTRODUCTION

1.1.Report description
1.2.Key benefits for stakeholders
1.3.Key market segments
1.4.Research methodology

1.4.1.Secondary research
1.4.2.Primary research
1.4.3.Analyst tools and models
1.4.4.Primary research

CHAPTER 2:EXECUTIVE SUMMARY

2.1.Key findings of the study
2.2.CXO perspective

CHAPTER 3:MARKET OVERVIEW

3.1.Market definition and scope
3.2.Key findings

3.2.1.Top investment pockets
3.2.2.Top player positioning, 2019

3.3.Porters five forces analysis
3.4.Market dynamics

3.4.1.Drivers

3.4.1.1.Increasing number of patients suffering from respiratory disease
3.4.1.2.Advancements in cough syrup product
3.4.1.3.Rise in elderly population

3.4.2.Restraints

3.4.2.1.Cough syrup abuse
3.4.2.2.Stringent rules and regulation in the developed countries

3.4.3.Opportunity

3.4.3.1.Emerging market

3.5.COVID-19 impact analysis for cough syrup market

CHAPTER 4:COUGH SYRUP MARKET, BY PRODUCT TYPE

4.1.Overview

4.1.1.Market size and forecast

4.2.Expectorants

4.2.1.Key market trends, growth factors, and opportunities
4.2.2.Market size and forecast, by region
4.2.3.Market analysis, by country

4.3.Cough suppressants

4.3.1.Key market trends, growth factors, and opportunities
4.3.2.Market size and forecast, by region
4.3.3.Market analysis, by country

4.4.Combination medications

4.4.1.Key market trends, growth factors, and opportunities
4.4.2.Market size and forecast, by region
4.4.3.Market analysis, by country

CHAPTER 5:COUGH SYRUP MARKET, BY AGE GROUP

5.1.Overview

5.1.1.Market size and forecast

5.2.Pediatric

5.2.1.Market size and forecast, by region
5.2.2.Market analysis, by country

5.3.Adult

5.3.1.Market size and forecast, by region
5.3.2.Market analysis, by country

CHAPTER 6:COUGH SYRUP MARKET, BY DISTRIBUTION CHANNEL

6.1.Overview

6.1.1.Market size and forecast

6.2.Retail Pharmacy

6.2.1.Market size and forecast, by region
6.2.2.Market analysis, by country

6.3.Hospital Pharmacy

6.3.1.Market size and forecast, by region
6.3.2.Market analysis, by country

6.4.Online Pharmacy

6.4.1.Market size and forecast, by region
6.4.2.Market analysis, by country

CHAPTER 7:COUGH SYRUP MARKET, BY REGION

7.1.Overview

7.1.1.Market size and forecast

7.2.North America

7.2.1.Key market trends, growth factors, and opportunities
7.2.2.North America Cough syrup market, by country

7.2.2.1.U.S. Market size and forecast, by product type
7.2.2.2.U.S. Market size and forecast, by age group
7.2.2.3.U.S. Market size and forecast, by distribution channel
7.2.2.4.Canada Market size and forecast, by product type
7.2.2.5.Canada Market size and forecast, by age group
7.2.2.6.Canada Market size and forecast, by distribution channel
7.2.2.7.Mexico Market size and forecast, by product type
7.2.2.8.Mexico Market size and forecast, by age group
7.2.2.9.Mexico Market size and forecast, by distribution channel

7.2.3.North America market size and forecast, by product type
7.2.4.North America market size and forecast, by age group
7.2.5.North America Market size and forecast, by distribution channel

7.3.Europe

7.3.1.Key market trends, growth factors, and opportunities
7.3.2.Europe Cough syrup market, by country

7.3.2.1.Germany Market size and forecast, by product type
7.3.2.2.Germany Market size and forecast, by age group
7.3.2.3.Germany Market size and forecast, by distribution channel
7.3.2.4.France Market size and forecast, by product type
7.3.2.5.France Market size and forecast, by age group
7.3.2.6.France Market size and forecast, by distribution channel
7.3.2.7.UK Market size and forecast, by product type
7.3.2.8.UK Market size and forecast, by age group
7.3.2.9.UK Market size and forecast, by distribution channel
7.3.2.10.Italy Market size and forecast, by product type
7.3.2.11.Italy Market size and forecast, by age group
7.3.2.12.Italy Market size and forecast, by distribution channel
7.3.2.13.Spain Market size and forecast, by product type
7.3.2.14.Spain Market size and forecast, by age group
7.3.2.15.Spain Market size and forecast, by distribution channel
7.3.2.16.Rest of Europe Market size and forecast, by product type
7.3.2.17.Rest of Europe Market size and forecast, by age group
7.3.2.18.Rest of Europe Market size and forecast, by distribution channel

7.3.3.Europe market size and forecast, by product type
7.3.4.Europe market size and forecast, by age group
7.3.5.Europe Market size and forecast, by distribution channel

7.4.Asia-Pacific

7.4.1.Key market trends, growth factors, and opportunities
7.4.2.Asia-Pacific Cough syrup market, by country

7.4.2.1.Japan Market size and forecast, by product type
7.4.2.2.Japan Market size and forecast, by age group
7.4.2.3.Japan Market size and forecast, by distribution channel
7.4.2.4.China Market size and forecast, by product type
7.4.2.5.China Market size and forecast, by age group
7.4.2.6.China Market size and forecast, by distribution channel
7.4.2.7.Australia Market size and forecast, by product type
7.4.2.8.Australia Market size and forecast, by age group
7.4.2.9.Australia Market size and forecast, by distribution channel
7.4.2.10.India Market size and forecast, by product type
7.4.2.11.India Market size and forecast, by age group
7.4.2.12.India Market size and forecast, by distribution channel
7.4.2.13.Rest of Asia-Pacific Market size and forecast, by product type
7.4.2.14.Rest of Asia-Pacific Market size and forecast, by age group
7.4.2.15.Rest of Asia-Pacific Market size and forecast, by distribution channel

7.4.3.Asia-Pacific market size and forecast, by product type
7.4.4.Asia-Pacific market size and forecast, by age group
7.4.5.Asia-Pacific Market size and forecast, by distribution channel

7.5.LAMEA

7.5.1.Key market trends, growth factors, and opportunities
7.5.2.LAMEA Cough syrup market, by country

7.5.2.1.Brazil Market size and forecast, by product type
7.5.2.2.Brazil Market size and forecast, by age group
7.5.2.3.Brazil Market size and forecast, by distribution channel
7.5.2.4.Saudi Arabia Market size and forecast, by product type
7.5.2.5.Saudi Arabia Market size and forecast, by age group
7.5.2.6.Saudi Arabia Market size and forecast, by distribution channel
7.5.2.7.South Africa Market size and forecast, by product type
7.5.2.8.South Africa Market size and forecast, by age group
7.5.2.9.South Africa Market size and forecast, by distribution channel
7.5.2.10.Rest of LAMEA Market size and forecast, by product type
7.5.2.11.Rest of LAMEA Market size and forecast, by age group
7.5.2.12.Rest of LAMEA Market size and forecast, by distribution channel

7.5.3.LAMEA market size and forecast, by product type
7.5.4.LAMEA market size and forecast, by age group
7.5.5.LAMEA Market size and forecast, by distribution channel

CHAPTER 8:COMPANY PROFILES

8.1.Abbott Laboratories

8.1.1.Company overview
8.1.2.Company snapshot
8.1.3.Operating business segments
8.1.4.Product portfolio
8.1.5.Business performance
8.1.6.Key strategic moves and developments

8.2.Acella Pharmaceuticals, LLC

8.2.1.Company overview
8.2.2.Company snapshot
8.2.3.Operating business segments
8.2.4.Product portfolio

8.3.GlaxoSmithKline plc

8.3.1.Company overview
8.3.2.Company snapshot
8.3.3.Operating business segments
8.3.4.Product portfolio
8.3.5.Business performance

8.4.Johnson & Johnson services Inc.

8.4.1.Company overview
8.4.2.Company snapshot
8.4.3.Operating business segments
8.4.4.Product portfolio
8.4.5.Business performance

8.5.Merck KGaA

8.5.1.Company overview
8.5.2.Company snapshot
8.5.3.Operating business segments
8.5.4.Product portfolio
8.5.5.Business performance
8.5.6.Key strategic moves and developments

8.6.Novartis International AG

8.6.1.Company overview
8.6.2.Company snapshot
8.6.3.Operating business segments
8.6.4.Product portfolio
8.6.5.Business performance

8.7.Pfizer Inc.

8.7.1.Company overview
8.7.2.Company snapshot
8.7.3.Operating business segments
8.7.4.Product portfolio
8.7.5.Business performance
8.7.6.Key strategic moves and developments

8.8.Procter & Gamble

8.8.1.Company overview
8.8.2.Company snapshot
8.8.3.Operating business segments
8.8.4.Product portfolio
8.8.5.Business performance

8.9.Reckitt Benckiser Group Plc.

8.9.1.Company overview
8.9.2.Company snapshot
8.9.3.Operating business segments
8.9.4.Product portfolio
8.9.5.Business performance

8.10.Sanofi

8.10.1.Company overview
8.10.2.Company snapshot
8.10.3.Operating business segments
8.10.4.Product portfolio
8.10.5.Business performance
8.10.6.Key strategic moves and developments

OUR CLIENTS

500 N Michigan Ave, Suite 600, Chicago, Illinois 60611, UNITED STATES
+18882123539
sales@reportocean.com